Health
1 in 10[1] people and 1 in 2 diabetics[2] suffer from Peripheral Neuropathy while 80% of patients remain undiagnosed[3]
Leading Global Health Experts converge at P&G's 'Demystifying Neuropathy Forum' to address the growing Public Health Concern of Peripheral Neuropathy MUMBAI, India, May 22, 2023 /PRNewswire/ -- As part of Neuropathy Awareness Week 2023, P&G Health, brought together globally renowned health expert...
2023-05-22 11:45
823
![1 in 10[1] people and 1 in 2 diabetics[2] suffer from Peripheral Neuropathy while 80% of patients remain undiagnosed[3]](https://mma.prnasia.com/media2/2081952/P_G_Neuropathy_Awareness_Week_2023_Roundtable.jpg?p=medium600)
Oncoclínicas Group records a net revenue of BRL 41 million for Q123
The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SAO PAULO, May 22, 2023 /PRNewswire/ -- Oncoclínicas Group (ONCO3) - the largest group dedicated to cancer treatment inLatin America - announced its results for the first quarte...
2023-05-22 11:18
2376
Chula's Faculty of Dentistry Continues to Standout as the Only Thai Institution in the World's TOP 70 and Second in ASEAN in the QS World University Rankings by Subject 2023
BANGKOK, May 22, 2023 /PRNewswire/ -- With its outstanding contribution to research, creative innovations, advancements and developments, the QS World University Rankings by Subject 2023 has, for the first time, placed the Faculty of Dentistry,Chulalongkorn University in the world's TOP 70 for De...
2023-05-22 10:00
2091
One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction
Beyond Simple HMW DNA extraction at scale. SINGAPORE, May 22, 2023 /PRNewswire/ -- One BioMed, announced today the launch of the X8™ HMW DNA Cartridge Kits for the automated extraction of high molecular weight DNA for use in long-read sequencing and genome assembly. Inclusive of all the necessa...
2023-05-22 08:00
2789
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102
SHANGHAI and WARREN, N.J. , May 21, 2023 /PRNewswire/ -- Laekna, a clinical-stage biotechnology company dedicated to bringing novel therapies to cancer and liver fibrosis patients worldwide, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug ...
2023-05-21 22:23
2039
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter
SINGAPORE, May 19, 2023 /PRNewswire/ -- EUDA Health Holdings Limited (the "Company" or "EUDA") (NASDAQ: EUDA, EUDAW), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, announced today that it received a delinquency notifica...
2023-05-20 04:05
5498
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'
Ticker symbol change effective at the market open May 22, 2023 NEW YORK, May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans...
2023-05-20 00:55
4898
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial
* Positive primary endpoint result of objective response rate (ORR) from the planned interim analysis of Phase II trial in advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJ). * Top-line data of the final analysis from Phase II to be announced in the second half of next year. S...
2023-05-19 21:00
2172
Health In Tech Partners with Health Direct Partners to provide self-funded employer groups with full plan transparency, savings, and improved employee health.
The revolutionary collaboration brings a robust medical management system to groups nationwide. STUART, Fla., May 19, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and reimagines self-funded health plans, is thrilled to announce it...
2023-05-19 20:30
2112
2023 Qingdao∙ Global Venture Capital Conference Comes to a Close
QINGDAO, China, May 19, 2023 /PRNewswire/ -- On the afternoon of May 13, 2023, theQingdao∙ Global Venture Capital Conference officially ended. Over the past two days, more than 1,000 leading investors, economists, entrepreneurs and representatives from financial institutions in the field of ventu...
2023-05-19 20:00
2114
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023
- New investigational data evaluating Fexuprazan in a Korean clinical trial program for healing erosive esophagitis (EE) regardless of food intake, and in a Chinese pivotal clinical trial program for the treatment of EE SEOUL, South Korea and CHICAGO, May 19, 2023 /PRNewswire/ -- Daewoong Pharm...
2023-05-19 20:00
1995
The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code
GUANGZHOU, China, May 19, 2023 /PRNewswire/ -- Global healthcare takes center stage as the world recovers from the COVID-19 pandemic. As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment. In the ...
2023-05-19 19:49
2043
Hisense HD60 Demonstrated in Clinical Training at University Hospital of Valdecilla in Spain
CAPE TOWN, South Africa, May 19, 2023 /PRNewswire/ -- Hisense, a manufacturer and provider of high-performance electronics and medical devices, recently participated atSpain's University Hospital of Valdecilla clinical ultrasound in traumatology training program as part of the company's effort of...
2023-05-19 19:37
1766
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease
* Tanfanercept did not demonstrate statistical significance in either of the primary outcome measures of improvement in central corneal staining score (CCSS) or in improvement in Eye Dryness Score (EDS) assessed at week 8 in subjects with dry eye disease (DED), compared to vehicle. * However,...
2023-05-19 19:00
1886
Another Hisense HD60 Ultrasound Installation at Vaal Radiology, South Africa
CAPE TOWN, South Africa, May 19, 2023 /PRNewswire/ -- Hisense, a manufacturer and provider of high-performance electronics and medical devices, has recently installed the Hisense Ultrasound HD60 at Vaal Radiology, a medical imaging center in Vereeninging,South Africa. This color Doppler ultrasoun...
2023-05-19 17:58
1771
Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey
The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 19, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...
2023-05-19 16:38
2970
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)
- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three exosome...
2023-05-19 16:34
2965
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial
SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue without modifications to move on to the second stage, based on the positive result of the interim...
2023-05-19 16:00
1785
EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden
PARIS, May 19, 2023 /PRNewswire/ -- On May 17th 2023, the six-month result of the SMART Study (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) was released on the Late Breaking Clinical Trial conference, reporting ground-breaking findings in the field o...
2023-05-19 14:54
1680
The Seventy-sixth World Health Assembly: Urgent global action to prioritise mental health
LONDON, May 19, 2023 /PRNewswire/ -- As WHO Member States, funders, health practitioners, civil society organisations and businesses engage at the Seventy-sixth World Health Assembly inGeneva, Switzerland from 21st – 30th May, under the theme "WHO at 75: Saving lives, driving health for all", the...
2023-05-19 06:00
2725
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 253 media titles]
2024-04-30 15:13Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
10615
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7522
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
6790
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
6390
